180
Participants
Start Date
December 6, 2016
Primary Completion Date
December 11, 2019
Study Completion Date
December 11, 2019
Rheosorbilact®
Administered intravenously (with speed 40-60 drip per minute) at a dose of 600 to 1,000 ml (10 to 15 ml/kg body weight per 24 hours) for 3 days.
Ringer lactate
Administered intravenously (with speed 40-60 drip per minute) at a dose of 1,000 to 2,500 ml (15 to 40 ml/kg body weight per 24 hours) for 3 days.
Central District Clinical Hospital, Vinnitsa
Khmelnytskyi Regional Clinical Hospital, Khmelnytskyi
Dnipro's Medical Academy of Ministry of Health of Ukraine, Dnipro
Zaicev's Institute of general and urgent surgery NMA Ukraine, Kharkiv
Zaporizka Medical Academy of postgraduate education, Zaporizkyi Clinical Hospital N9, Zaporizhzhya
"Unimedi Adjara LLC", Batumi
Kutaisi Referral Hospital, Kutaisi
Hospital of the Medical Center of the Administration of the President of the Republic of Kazakhstan, Astana
Institute of Ambulance, Chisinau
"Municipal Clinical Hospital Sfinta Treime", Chisinau
Republican Clinical Hospital, Chisinau
"HSEE of Ukraine Ukrainian Medical Stomatological Academy; Poltava Central District Hospital", Poltava
Republic Centre of Ambulance, Tashkent
Yuria-Pharm
INDUSTRY